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Current cell biology textbooks mention only two kinds of cell-to-cell adhering junctions coated with the cytoplasmic plaques:
the desmosomes (maculae adhaerentes), anchoring intermediate-sized ﬁlaments (IFs), and the actin microﬁlament-anchoring
adherens junctions (AJs), including both punctate (puncta adhaerentia) and elongate (fasciae adhaerentes) structures. In addition,
however, a series of other junction types has been identiﬁed and characterized which contain desmosomal molecules but do not
ﬁt the deﬁnition of desmosomes. Of these special cell-cell junctions containing desmosomal glycoproteins or proteins we review
the composite junctions (areae compositae) connecting the cardiomyocytes of mature mammalian hearts and their importance
in relation to human arrhythmogenic cardiomyopathies. We also emphasize the various plakophilin-2-positive plaques in AJs
(coniunctiones adhaerentes) connecting proliferatively active mesenchymally-derived cells, including interstitial cells of the heart
and several soft tissue tumor cell types. Moreover, desmoplakin has also been recognized as a constituent of the plaques of the
complexus adhaerentes connecting certain lymphatic endothelial cells. Finally, we emphasize the occurrence of the desmosomal
transmembrane glycoprotein, desmoglein Dsg2, out of the context of any junction as dispersed cell surface molecules in certain
types of melanoma cells and melanocytes. This broadening of our knowledge on the diversity of AJ structures indicates that it may
still be too premature to close the textbook chapters on cell-cell junctions.
1.Introduction
Typical desmosomes (maculae adhaerentes) are cell-cell
junctions connecting cells of epithelial, meningothelial, and
myocardial nature or malignantly transformed cells derived
therefrom. Over the past two decades the molecular and
ultrastructural organization of diverse cell-cell-connecting
plasma membrane structures has been elucidated and two
novel categories and architectonic principles have been
recognized: desmosomal molecules as functionally impor-
tant components of special non-desmosomal junctions and
the existence of certain desmosomal molecules in a non-
junction-bound form.
2.The Desmosomes of Stratiﬁed and
Other Epithelia
The ultrastructural organization and the high lateral packing
density of desmosomes in the epidermis or other multi-
stratiﬁed vertebrate epithelia is best seen in the electron
microscope (e.g., Figure 1), and the corresponding protein
compositions of the various desmosomal subtypes in the
speciﬁc strata have been determined by biochemical analyses
and immunolocalization techniques [1–7].
In most stratiﬁed epithelia, epidermis included, the
desmosome packing density is so high that more than half
of the entire cell-cell membrane contact area is represented2 Dermatology Research and Practice
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Figure 1: High-magniﬁcation electron micrograph of two cross
sectioneddesmosomalstructuresconnectingstratumspinosumcells
of human fetal (20wk) foot-sole epidermis. Brackets and label
“P”: cytoplasmic dense plaque; black arrows: midline structure;
white arrows: trilaminar “unit membrane” structure of the plasma
membrane; arrowheads (top and bottom): secondary dense layer of
the plaque; IF: intermediate-sized ﬁlaments (for further details see
[7]); PM: plasma membrane. Bar: 0.1μm.
by desmosomal structures. Using immunohistochemical
techniques with desmosomal markers this high packing
density is directly demonstrable not only for all layers of the
highly corniﬁed mammalian epidermis but also in the skin
of lower vertebrates such as ﬁshes and amphibia (Figure 2(a)
shows the immunolocalization of plakoglobin on a sec-
tion of ﬁxed, paraﬃn-embedded skin of the eel, Anguilla
anguilla; Figure 2(b) shows desmoplakin immunostaining
on the skin of the frog, Rana pipiens; for details see [8]).
Clearly, in stratiﬁed epithelia the desmosomal constituents
are, together with the keratin ﬁlaments, among the most
frequent proteins. Moreover, the molecular composition of
theepidermaldesmosomes—andthoseofsimilarmultistrat-
iﬁed epithelia—has been found to show fundamental strata-
speciﬁc diﬀerences, notably with respect to the desmogleins,
Dsg1-4, the desmocollins, Dsc1-3, and the plaque proteins
plakophilins, Pkp1-3 (Table 1 and [4–6, 9]).
The stratum-speciﬁc molecular ensembles, speciﬁcally
the Dsg and Dsc glycoproteins, are also of marked impor-
tance with respect to the pathogenesis of autoimmune skin
diseases of the pemphigus type which show a more or less
direct correlation with the speciﬁc desmosomal glycoprotein
complement of the aﬀected layer (see, e.g., [4, 6, 9, 24–
28]).Theseautoimmunediseasesarespeciﬁcallydealtwithin
otherarticlesofthisissue.Anotheraspectofthedesmosomal
arrays in the epidermis and other stratiﬁed epithelia is their
frequent—in some areas almost regular—punctuation by
very small “sandwich junctions” (iuncturae structae)c o n -
sec
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Figure 2: Immunoﬂuorescence microscopy of cryostat sections
through ﬁsh and amphibian skin, showing the localization of
desmosomal components in all layers of the epidermis. (a)
Immunoﬂuorescence labeling of plakoglobin (red), in addition to
nuclear DAPI staining (blue), in a section through the paraﬃn-
embedded skin of an eel (Anguilla anguilla). The section is shown
after antigen retrieval and immunoreaction (for methods see [8])
using a monoclonal mouse plakoglobin antibody (mAb PG 5.1;
Progen Biotechnik, Heidelberg, Germany). Note the distinct basal
layer (stratum basale) of the epidermis and the relatively large
club shaped cells (“club cells”) as well as the mucous goblet cells
and the dense-packed apical cell layers. (b) Immunoﬂuorescence
labeling of desmoplakin on a cryostat section through the skin
of the frog, Rana pipiens, using mAb DP447 (Progen Biotechnik).
Note the continuous pattern of very closely spaced, ﬁnely punctate
staining of the epidermal desmosomes. Bl: basal layer; cc: club
cells; gc: goblet cells; sec: superﬁcial epithelial cells (for histological
terminology see [8]). Bar in (a): 100μm; bar in (b): 50μm.
taining the four times-membrane-spanning tight junction
hallmark protein, occludin [29, 30].
3. The Composite Junctions of
the IntercalatedDisks (IDs)
ConnectingMammalianCardiomyocytes
In mammals the development of the ID junctional system
connecting cardiomyocytes does not stop at birth but
continues postnatally [15, 31, 32]. In particular the two
types of adhering junctions originally distinguishable show
further polar translocation, accumulation in the ID regionDermatology Research and Practice 3
Table 1: Shown are speciﬁc cell-cell adhering junctions containing transmembrane glycoproteins and cytoplasmic plaque proteins of
“classic” desmosomes and adherens junctions (AJs). Special types of adhering junctions containing desmosomal proteins in human tissues
and cell cultures.
Type Cells Transmembrane
glycoproteins
Some representative
plaque proteins References
Macula adhaerens
(desmosome)
Epithelial and
mesothelial cells and
carcinomas derived
therefrom,
cardiomyocytes of
immature hearts and
c a r d i a cc o n d u c t i v ec e l l s
Desmogleins-1-4
Desmocollins-1-3
Plakophilins-1-3
Plakoglobin
Desmoplakin
Franke et al. [10, 11]
Cowin et al. [12]
Mertens et al. [13]
Area composita
(composite junction)
Cardiomyocytes and
Purkinje ﬁber cells
N-Cadherin
Cadherin-11
Desmoglein-2
Desmocollin-2
α-a n dβ-Catenin
Proteins p120, p0071
and
ARVCF
Plakoglobin
Plakophilin-2
Desmoplakin
Afadin
Myozap
Franke et al. [14]
Pieperhoﬀ and
Franke [15]
Goossens et al. [16]
Seeger et al. [17]
Complexus adhaerens
Certain endothelia
(spec. endothelial and
virgultar tissues of
lymph node sinus)
VE-Cadherin
N-Cadherin
Claudin-5
JAM-A
α-a n dβ-Catenin
Protein p120
Plakoglobin
Desmoplakin, Afadin
Schmelz and Franke
H¨ ammerling et al.
[18]
Moll et al. [19]
Zona limitans externa Neural retina N-Cadherin
Neurojungin
α-a n dβ-Catenin
Plakoglobin
Plakophilin-2
Paﬀenholz et al. [20]
Colligatio permixta Astrocytes and
astrocytoma cells
N-Cadherin
Cadherin-11
VE-Cadherin
α-a n dβ-Catenin
Protein p120
Plakoglobin
Plakophilin-2
Afadin
Boda-Heggemann
et al. [21]
Coniunctio adhaerens
Mesenchymally derived
cells of high
proliferative activity in
situ and in culture
N-Cadherin
Cadherin-11
α-a n dβ-Catenin
Proteins p120 and
p0071
Plakoglobin
Plakophilin-2
[Plakophilin-3]
Afadin
Rickelt et al. [22]
Barth et al. [23]
and fusions of the desmosomal and the fascia adhaerens
components, accompanied by an increasing amalgamation
of the two kinds of molecular ensembles into the new mixed
category of area composita (AC) structures (Figures 3(a)–
3(c),4(b),and5(a);fordetailsofmolecularlocalizationsand
biochemical analyses see [14, 15, 33]; for non-mammalian
species see however [8, 34]). As a typical result rather
extended AC structures are seen which combine composi-
tional and ultrastructural properties of desmosomes with
those of AJs (Figures 3 and 4(b)). In addition, the “mixed
AC ensembles” of the ID (Table 1; Figure 4(b)) include
a series of additional proteins such as α-T-catenin [16]
and the recently identiﬁed plaque protein called “myozap”
[17]. The special organizational importance of certain
armadillo-type proteins, in particular plakoglobin and
plakophilin-2, for the entire ID contact of cardiomyocytes
has also been demonstrated for early stages of murine heart
formationintheabsenceofthegenesencodingtheseproteins
[35, 36] and in siRNA-downregulation experiments ([37–
39], for related experiments see also [40, 41]).
The physiological and medical importance of desmoso-
mal molecules in the composite junctions of the myocar-
diac IDs is most impressively demonstrated by the recent
avalanche of publications that speciﬁc mutations in genes
encoding desmosomal proteins can result in arrhythmogenic
cardiomyopathies (ARVC/D), mostly in the right ventricle
but left ventricle damages have also been reported (Table 2).
Here the gene encoding plakophilin-2 appears to be espe-
cially vulnerable as defects in this gene alone seem to
account for about two thirds of the cases. This category of
ARVC/D-based diseases and “sudden death” events resulting
from altered desmosomal proteins also includes complex
hereditary syndromes such as combinations of dermatolog-
ical disorders (“woolly hair”, diverse patterns of striate and4 Dermatology Research and Practice
(a)
(b)
(c)
Figure 3: Micrographs showing the immunolocalization of the
desmosomal plaque protein, desmoplakin, on cryostat sections
through the murine myocardium. (a) Immunoﬂuorescence micro-
graph showing the localization of desmoplakin (red) in all
composite junction structures of the intercalated disks (IDs).
(b) Immunoﬂuorescence micrograph showing desmoplakin (red)
labeling of the composite junctions on the background of phase-
contrast optics. (c) Merged image showing plakophilin-2 (red), β-
catenin (green) and nuclear DAPI-staining (blue), on an interfer-
ence contrast microscopy background. Composite junctions (CJs)
are characterized by their yellow merge colour whereas the zonulae
adhaerentes and other AJs of the capillary endothelial cell layers
here show only β-catenin-positivity. Bar in (a): 100μm; bar in (b):
50μm; bar in (c): 25μm.
diﬀuse keratoderma changes, particularly in palmoplantar
skin) and cardiac disease features such as in the classic
“Naxos disease” type or the “Carvajal syndrome” subtype,
ﬁrst identiﬁed in the year 2000 in three Ecuadorian families,
which may also include damages in both ventricles (for an
anthology see [42]). The speciﬁc dominant and recessive
forms of the human diseases ascribed to mutations of genes
encoding desmosomal proteins have been dealt with in
several speciﬁc recent review articles [42, 97–102].
4. Adhering Junctions inthe Specialized
Cellsof the CardiacConduction System
The specialized cells of the mammalian cardiac conduction
system are connected by three diﬀerent types of AJs [103]:
desmosomes, which in certain cell regions occur in impres-
sively high packing density, as well as AJs and CJs (Figures
5(b)–5(d)). The conductive cells of the ovine and bovine
Purkinje ﬁber systems have been studied in special detail
with respect to their nature as modiﬁed cardiomyocytes
and to the various forms of junctions of which a major
proportion is located at lateral cell-cell contact sites [103–
105]. These ﬁndings have led to the hypothesis that the
abundance of apparently “normal-looking” desmosomes in
Desmosome
Punctum adhaerens
Stud junction
Gap junction
(a)
Desmosome
Area composita
Gap junction
(b)
Figure 4: Schematic comparison of the diﬀerent principles of
organization of cell-cell junctions containing desmosomal proteins
in mammalian epidermal and myocardiac tissue. (a) Junction orga-
nizations between epidermal keratinocytes as observed in the stra-
tum spinosum. Note the densely spaced desmosomes (red plaques),
which anchor bundles of intermediate sized ﬁlaments contain-
ing keratins (dark-green). Smaller adherens junctions (puncta
adhaerentia, yellow plaques) anchor actin-microﬁlament bundles
(red ﬁlaments). Furthermore, special types of tight junction-like
structures, the small “stud junctions” (black dots), and channel-
like connexin paracrystals (gap junctions, blue) are also generally
found. For details see [29, 30]. (b) The area composita (composite
junction, orange) structures of intercalated disks (ID) connecting
cardiomyocytes of an adult mammalian heart. This amalgamated
type of adhering junction is characterized by a mixture of typical
desmosomal and AJ molecules. This kind of composite junction
is the predominating adhering junction structure in the ID of the
adult mammalian heart.
the conductive tissue might also—and perhaps primarily—
be aﬀected by the desmosomal protein mutations in cases
of human ARVC/D (Table 2), as also suggested from the
muchhigherconductionspeedofthese“cellﬁbers”(see,e.g.,
[103, 106, 107]).
The various size classes of the desmosomal protein-
rich junctions connecting conduction cells are presented by
desmoplakin immunoelectron microscopy in Figures 5(b)–
5(d), including some very small junctions (arrowheads inDermatology Research and Practice 5
Table 2: During the last few years an avalanche of publications has appeared—and is still continuing to do so—showing the involvement
of mutations in desmosomal components in the development of arrhythmogenic cardiomyopathies, including “sudden death” cases (for
references see [10–12, 38, 40, 42–96]). Recent references reporting that certain mutations in human genes encoding desmosomal proteins
and glycoproteins contribute to arrhythmogenic ventricular cardiomyopathies (ARVC).
Protein Reference
Plakophilin-2
Gerull et al. [43]
Antoniades et al. [44]
Calkins [45]
Nagaoka et al. [46]
Kannankeril et al. [47]
Dalal et al. [48]
Syrris et al. [49]
Tsatsopoulou et al. [50]
Van Tintelen et al. [51]
Awad et al. [60]
Lahtinen et al. [52]
Otterspoor et al. [53]
Fidler et al. [38]
Joshi-Mukherje et al. [54]
Ram and Van Wagoner, [55]
Tandri et al. [56]
Wu et al. [57]
Qiu et al. [58] (5 cases)
Hall et al. [40]
Bhuiyan et al. [59] (23 cases)
den Haan et al. [64] (21 cases)
Xu et al. [61] (38 cases)
Bauce et al. [62] (7 cases)
Cox et al. [95] (58 cases)
Desmoplakin
Norgett et al. [84]
Rampazzo and Danieli [97]
Alcalai et al. [86]
Bauce et al. [77]
Norman et al. [85]
Sen-Chowdhry et al. [87]
Norgett et al. [75]
Uzumcu et al. [74]
Sen-Chowdhry et al. [88]
Tsatsopoulou et al. [50]
Yang et al. [89]
den Haan et al. [64] (1 case)
Mahoney et al. [81]
Xu et al. [61] (10 cases)
Bauce et al. [62] (5 cases)
Cox et al. [95] (1 case)
Bolling et al. [96]
Desmoglein-2
Pilichou et al. [90]
Tsatsopoulou et al. [50]
Awad et al. [60]
Syrris et al. [73]
Yu et al. [91]
Bhuiyan et al. [59] (4 cases)
den Haan et al. [64] (8 cases)
Xu et al. [61] (10 cases)
Bauce et al. [62] (4 cases)
Cox et al. [95] (3 cases)
Desmocollin-2
Heuser et al. [83]
Syrris et al. [72]
Beﬀagna et al. [79]
Bhuiyan et al. [59] (2 cases)
Simpson et al. [76]
Xu et al. [61] (4 cases)
Bauce et al. [62] (2 cases)
Cox et al. [95] (3 cases)
Plakoglobin
McKoy et al. [80]
Protonotarios et al. [78, 82]
Kaplan et al. [71]
Garcia-Gras et al. [92]
Asimaki et al. [93]
Asimaki et al. [94]
den Haan et al. [64] (1 case)
Xu et al. [61] (2 cases)
Selectedreviewarticles:BazziandChristiano[65];Marcusetal.(Eds.)[42];Awadetal.[66];Corradoetal.[67];Herrenetal.[68];Saﬃtz[69];Sen-Chowdhry
et al. [63].
First animal model (boxer dog): Oxford et al. [70].
Figure 5(b)). Frequently, a number of individual desmin-
containing intermediate ﬁlaments can be resolved at such
junctions (e.g., Figure 5(c)), often revealing closely-parallel
plaque associations (e.g., arrows in Figure 5(d)).
5. Desmosomal PlaqueProteinsin
SpecialNon-Desmosomal Adhering
Junctions (Coniunctiones and
Complexus Adhaerentes)
Proteins of the plakophilin-subfamily of armadillo proteins
areconstitutive,apparentlynecessarycomponentsofdesmo-
somal plaques [13, 108–113]. Their special organizational
role and architectonic importance has been demonstrated
perhaps most convincingly in the case of plakophilin-2 by
geneabrogationaswellassiRNA-mediatedmRNAreduction
experiments [36, 37, 39–41]. Moreover, the functional
importance of some plakophilins, in particular plakophilin-
2, may extend beyond desmosomal plaques to gap junctions
[37, 38] and into the interior of the cell, including certain
c y t o p l a s m i ca sw e l la sn u c l e a rc o m p l e x e s[ 114–116].
Recently, however, we have discovered that the occur-
rence of both plakophilin-2 and plakophilin-3 is not neces-
sarily restricted to the plaques of desmosomes but that these
proteins can also occur as constitutive molecules in plaques
of some non-desmosomal junctions such as the puncta
adhaerentia-like AJs of certain cell cultures [22, 23, 117]
orinproliferativelyactivecellsofcertaintumors,forexample
in cardiac myxomata [118]. Here the rapid acquisition6 Dermatology Research and Practice
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Figure 5: Immunoelectron microscopy of ultrathin sections through bovine myocardium (a) and Purkinje ﬁbers ((b)–(d)) using antibodies
against desmoplakin. (a) Immunogold labeling of a typical extended area composita structure in an intercalated disk (ID) of adult
cardiomyocytes. (b) By contrast, note the relatively small desmoplakin-positive junctions that connect cells of the Purkinje ﬁber conductive
system ((d), desmosomes; arrowheads denote some particularly small desmosome-like junction structures with asymmetric labeling).
The desmoplakin-rich plaques of such junctions are very intensely labeled. (c) The morphology and the relatively close packing of the
major type of junctions are similar to those of the area composita structures of adult mammalian cardiomyocytes. (d) High-magniﬁcation
immunoelectron micrograph of a composite junction. Note the very close near parallel association of intermediate-sized ﬁlaments (some
are denoted by arrows) with junctional plaques. Bars in (a) and (b): 1μm; bar in (c): 0.25μm.
(a)
(b) (d) (e) (c)
(a’)
Figure 6: Double-label immunoﬂuorescence micrographs, showing the localization of the “desmosomal protein”, plakophilin-2, in
mesenchymally derived cultures of valvular interstitial cells (VICs). (a), (a) Phase contrast and immunoﬂuorescence micrograph showing
ovine VICs forming clusters of AJs positive for the typical desmosomal plaque component plakophilin-2 (red; vimentin ﬁlaments are labeled
in green). (b)–(d) Represent merged images of ovine VICs, showing colocalization staining (yellow) of plakophilin-2 (red) with typical AJ
proteins such as cadherin-11 (green, (b)), β-catenin (green, (c)), protein p120 (green, (d)) all on a phase contrast background. (e) Human
VICs exhibit similar colocalization of plakophilin-2 (red) here with N-cadherin (green) as shown by the yellow merge colour (for further
details see [23]). Bar in (a): 25μm; bar in (b): 30μm; bars in (c) and (d): 20μm; bar in E: 10μm.Dermatology Research and Practice 7
of plakophilin-2 to the non-desmosomal plaques of these
tumor cell AJs, in particular the fact that it appears in the
earliest in vitro culture passages of cardiac valvular inter-
stitial cells from various mammalian species [23], suggests
that the addition of plakophilin-2 alone—or together with
plakophilin-3—to these junctions is somehow related to the
induction of proliferation and cell cycle growth. It is there-
forelikelythatinthefuturethesystematicexaminationofthe
presence of plakophilins in such AJs will give valuable diag-
nostic informations. Figures 6(a)–6(e) present the early inte-
gration of plakophilin-2 into a series of small puncta adhaer-
entia connecting interstitial cells freshly brought from car-
diac valve matrix tissue into cell culture (for details see [23]).
The junctional system connecting the endothelial cells
of blood and lymph vessels is obviously of great biological
importance and has been studied extensively (reviews: [119,
120]). There is, however, a special category of variously-sized
and -shaped AJs which connect certain types of endothelial
cells in some parts of the lymphatic system, including the
three-dimensionally branched “virgultar” cells of lymph
node sinus as well as speciﬁc cutaneous and other peripheral
lymph capillaries, which are characterized by AJs containing
in addition desmoplakin as a major plaque protein, in most
cases probably in combination with plakoglobin [18, 121–
123]. The existence of such complexus adhaerentes in special
parts of the vascular endothelial system has since been
conﬁrmed several times ([124–126], for a recent review
see [19]). The formation of plaque complexes of VE-
cadherin with desmoplakin and plakoglobin has also been
demonstrated for dermal capillary endothelium in special
molecular assembly experiments [127].
Beyond this role of desmoplakin as a regular constituent
of the plaques of such “complex junctions” in certain
lymphatic endothelia of the mature body a fundamental
and general role of desmoplakin in the formation of the
vascular endothelial system is also indicated by the transgene
embryogenesis studies of Gallicano et al. [128, 129]. Thus,
the complexus adhaerens junctions have to be added to the
list of novel kinds of adhering junctions in their own right
(see Table 1; for recent reviews see: [19, 130, 131]).
6. Dispersed,Non-Junction Bound Statesof
Desmosomal Cadherins:DesmogleinDsg2
Desmosomal cadherins typically associate with each other
andformclose-packedcis-clustersinthemembranesofcyto-
plasmic vesicles, then exocytose to form a “half-junction”
on the cell surface and under suﬃcient Ca2+-concentration
may further associate head-to-head in transform with
another “half-junction”, usually a domain of an adjacent
cell, to a symmetrical junction [132–137]. Isolated, that
is, non-junction-bound, desmosomal cadherin molecules
that have not been included in desmosome structures and
consequently may be dispersed over extended parts of the
plasma membrane until recently had not been observed
in natural cells. Only in certain cell culture lines deﬁcient
of most junction components such as the human ﬁbrosar-
coma HT-1080 cells states of the isolated desmosomal
cadherin, Dsg2, have been described to occur on cell
surfacesandcouldbeintegratedinto junction-like structures
only upon introduction of further desmosomal proteins
[137, 138].
Thus it was with great surprise when we noted the
occurrence of Dsg2 molecules dispersed over large portions
of the surface membrane of certain cultures of human
m e l a n o c y t e so rn e v a lc e l l sa sw e l la so ns u r f a c e so fa
subtype of melanoma cells in situ and in culture [139,
140]. As far as it could be concluded from the biochemical
analyses and immunolocalization experiments so far per-
formed, these Dsg2 glycoprotein molecules were not stably
complexed with speciﬁc other transmembrane or with any
plaque molecules but nevertheless seemed to be somehow
involved in close membrane-to-membrane associations. It is
obvious that such stages, that is, dispersed, non-junction-
bound desmosomal cadherins will have to be studied with
special care as they point to the existence of yet unknown,
radically diﬀerent cell-cell adhesion mechanisms involving
desmosomal cadherins.
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